BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2677054)

  • 1. Use of monoclonal anti-actin as a megakaryocyte marker in paraffin wax embedded bone marrow biopsy specimens.
    Boqué C; Pujol-Moix N; Linde MA; Murcia C; Guanyabens C; Soler J
    J Clin Pathol; 1989 Sep; 42(9):982-4. PubMed ID: 2677054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies].
    Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F
    Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of APAAP technique on paraffin wax embedded bone marrow trephines.
    Erber WN; McLachlan J
    J Clin Pathol; 1989 Nov; 42(11):1201-5. PubMed ID: 2685054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of megakaryocytic cells by Ulex Europaeus Agglutinin I (UEA 1) in B5 fixed, decalcified, paraffin-embedded specimens.
    Liu SM; Liu HC
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Feb; 45(2):75-82. PubMed ID: 2168253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical staining of plastic embedded bone marrow trephine biopsy specimens after microwave heating.
    McCluggage WG; Roddy S; Whiteside C; Burton J; McBride H; Maxwell P; Bharucha H
    J Clin Pathol; 1995 Sep; 48(9):840-4. PubMed ID: 7490318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A megakaryocyte analysis of the bone marrow in patients with myelodysplastic syndrome, myeloproliferative disorder and allied disorders.
    Ohshima K; Kikuchi M; Takeshita M
    J Pathol; 1995 Oct; 177(2):181-9. PubMed ID: 7490685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens.
    Thiele J; Quitmann H; Wagner S; Fischer R
    J Clin Pathol; 1991 Apr; 44(4):300-5. PubMed ID: 2030148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemistry in bone marrow diagnosis. Value of a panel of monoclonal antibodies on routinely processed bone marrow biopsies.
    van der Valk P; Mullink H; Huijgens PC; Tadema TM; Vos W; Meijer CJ
    Am J Surg Pathol; 1989 Feb; 13(2):97-106. PubMed ID: 2464955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megakaryocyte apoptosis in immune thrombocytopenia.
    Vrbensky JR; Nazy I; Toltl LJ; Ross C; Ivetic N; Smith JW; Kelton JG; Arnold DM
    Platelets; 2018 Nov; 29(7):729-732. PubMed ID: 29787328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Willebrand factor is the most reliable immunohistochemical marker for megakaryocytes of myelodysplastic syndrome and chronic myeloproliferative disorders.
    Chuang SS; Jung YC; Li CY
    Am J Clin Pathol; 2000 Apr; 113(4):506-11. PubMed ID: 10761451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megakaryocytes in myelodysplasia: an immunohistochemical study on bone marrow trephines.
    Fox SB; Lorenzen J; Heryet A; Jones M; Gatter KC; Mason DY
    Histopathology; 1990 Jul; 17(1):69-74. PubMed ID: 1699866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase: a specific marker for myeloid cells in paraffin sections.
    Pinkus GS; Pinkus JL
    Mod Pathol; 1991 Nov; 4(6):733-41. PubMed ID: 1724087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QBEND10 for the diagnosis of myelodysplastic syndromes in routinely processed bone marrow biopsy specimens.
    Horny HP; Wehrmann M; Schlicker HU; Eichstaedt A; Clemens MR; Kaiserling E
    J Clin Pathol; 1995 Apr; 48(4):291-4. PubMed ID: 7542289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical evaluation of bone marrow biopsies in myelodysplastic syndromes.
    Soligo D; Luksch R; Quirici N; Foa P; Moneta D; Somalvico F; Lambertenghi Deliliers G
    Haematologia (Budap); 1991; 24(1):39-46. PubMed ID: 1813362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic megakaryocyte dysplasia in the myelodysplastic syndromes.
    Hatfill SJ; Fester ED; Steytler JG
    Hematol Pathol; 1992; 6(2):87-93. PubMed ID: 1607344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Megakaryocytopoiesis in different forms of thrombocytosis and thrombocytopenia: identification of megakaryocyte precursors by immunostaining of intracytoplasmic factor-VIII-related antigen.
    Knecht H; Streuli RA
    Acta Haematol; 1985; 74(4):208-12. PubMed ID: 3939062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of cell proliferation in formalin-fixed, wax-embedded bone marrow trephine biopsies using the monoclonal antibody PC10, reactive with proliferating cell nuclear antigen (PCNA).
    Wilkins BS; Harris S; Waseem NH; Lane DP; Jones DB
    J Pathol; 1992 Jan; 166(1):45-52. PubMed ID: 1347081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical evaluation of neoplasms in bone marrow biopsies using monoclonal antibodies reactive in paraffin-embedded tissue.
    Kubic VL; Brunning RD
    Mod Pathol; 1989 Nov; 2(6):618-29. PubMed ID: 2587569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of Ulex europaeus agglutinin 1 (UEA-1) binding of megakaryocytes in bone marrow biopsy specimens: demonstration of heterogeneity in staining pattern reflecting the stages of differentiation.
    Liu SM; Li CY
    Hematopathol Mol Hematol; 1996; 10(1-2):99-109. PubMed ID: 8792151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megakaryocytopoiesis and apoptosis in patients with myelodysplastic syndromes.
    Li X; Pu Q
    Leuk Lymphoma; 2005 Mar; 46(3):387-91. PubMed ID: 15621828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.